Evolus, Inc.
Industry: Life Sciences ・ $EOLS on Nasdaq
Insider Sale
+$6,010,758
-46.92%
Shares
Shares Volume: 471,432 Shares
Average Share Price: $12.75
INSIDER
MOATAZEDI DAVID
See Remarks (Director)
reported on Jun 6 2024
traded on Jun 4 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 533,349 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,245,308.95 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 1 / 20 |
| P/S VALUE RATIO | 0.128 |
| AVERAGE SALE VALUE | $506,300.11 |
| COMPANY PREVIOUS TRADES |